ArticleHuman vaccines & immunotherapeutics2025
HPV vaccine awareness and vaccination status among women of reproductive age in Türkiye: A cross-sectional study.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- HPV knowledge, awareness, and vaccine beliefs among women attending gynecological care in Türkiye: implications for cervical cancer prevention.Infectious agents and cancer · 2026Article
- Association Between HPV Vaccination and Cervical Dysplasia Severity in HPV-Positive Women.Diagnostics (Basel, Switzerland) · 2026Article
- Awareness, factual knowledge, attitudes, and acceptability of human papillomavirus vaccination among adult women in Palestine: a cross-sectional study.Frontiers in global women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although Türkiye implemented a national cervical cancer screening program in 2014, the Human Papillomavirus (HPV) vaccine has yet to be included in the national immunization schedule. Consequently, HPV vaccination coverage remains remarkably low. This study aimed to evaluate HPV vaccine awareness, attitudes, and vaccination status among women aged 18-45 in Afyonkarahisar, Türkiye. This descriptive cross-sectional study was conducted at a gynecology and obstetrics outpatient clinic between September and December 2024. Data were collected through face-to-face interviews using a structured 11-item questionnaire. A total of 655 women aged 18-45 were included in the analysis. Only 46 (7.0%) reported being vaccinated against HPV. While 313 participants (51.4%) were aware of the HPV vaccine, most had not received it. Women who had not undergone cervical screening were significantly more likely to be vaccinated (OR = 4.6; 95% CI: 2.21-9.85;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.